UBS Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.79M | Buy |
|
|||||
|
2025
Q1 | $1.23M | Sell |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $1.94M | Buy |
|
|||||
|
2024
Q2 | $1.2M | Buy |
|
|||||
|
2024
Q1 | $781K | Sell |
|
|||||
|
2023
Q4 | $1.01M | Buy |
|
|||||
|
2023
Q3 | $573K | Sell |
|
|||||
|
2023
Q2 | $1.76M | Buy |
|
|||||
|
2023
Q1 | $1.59M | Buy |
|
|||||
|
2022
Q4 | $1.3M | Buy |
|
|||||
|
2022
Q3 | $2.14M | Sell |
|
|||||
|
2022
Q2 | $2.65M | Sell |
|
|||||
|
2022
Q1 | $3.57M | Sell |
|
|||||
|
2021
Q4 | $5.1M | Sell |
|
|||||
|
2021
Q3 | $6.83M | Sell |
|
|||||
|
2021
Q2 | $6.29M | Buy |
|
|||||
|
2021
Q1 | $2.5M | Buy |
|
|||||
|
2020
Q4 | $1.01M | Buy |
|